...for an Investigational Device Exemption is submitted to the FDA for approval, Theradaptive will initiate human clinical trials. CEO and founder of Theradaptive, Dr. Luis Alvarez, Ph.D., believes the funding...
Theradaptive was granted Breakthrough Medical Device designation by FDA for the use of OsteoAdapt SP in Anterior Lumbar Interbody Fusion. This is the third Breakthrough Designation for Theradaptive in spinal...
...significantly increases the number of patients who can potentially benefit from this game-changing device,” said John Greenbaum, Senior Vice President of Clinical & Regulatory Affairs at Theradaptive. Source: Theradaptive Favorite...
Theradaptive announced that FDA has granted Breakthrough Medical Device designation to its Osteo-Adapt SP Spinal Fusion implant indicated for transforaminal lumbar interbody spinal fusion to treat degenerative disc disease, spondylolisthesis...
Nov 22, 2021
Login
Sign Up
Login
Login
Register for a free account
As a guest member you get access to more articles and webinars every month.
